Akron Biotech

NEWS

Genetown

In Other (Biopharma) News: Non-Coronavirus Stories this Week

The following is a roundup of some of this week’s non-coronavirus biopharma news.

March 31, 2020

·

5 min read

·

IN THE PRESS

Press Releases

Nanotein engages Akron Bio for the cGMP production of its NanoSpark™ STEM-T Soluble T Cell Activator

October 9, 2024

·

3 min read

Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing

January 17, 2023

·

2 min read

Business

Akron Bio Appoints Christopher Murphy as Chief Executive Officer

December 12, 2022

·

1 min read

BioMidwest

Akron Bio Expands Commercialization of Advanced Gene Therapy and Vaccine Production with New Manufacturing Facility

April 13, 2022

·

2 min read

BioMidwest

Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment

October 19, 2020

·

2 min read

Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines

July 13, 2020

·

3 min read

Akron Biotech Expands to Second US Manufacturing Facility

March 30, 2020

·

3 min read

Policy

Akron Biotechnology publishes industry-wide recommendations for ATMP ancillary material regulation

January 22, 2020

·

2 min read

Deals

Arcline Investment Management Acquires Majority Interest In Cell And Gene Therapy Materials Supplier Akron Biotechnology

September 11, 2019

·

3 min read

Business

Akron Biotech Submits eCTD Drug Master File for IL-2 with the FDA

February 13, 2019

·

2 min read

JOBS